MENU
SPRY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ARS Pharmaceuticals (SPRY) Ownership - Who owns ARS Pharmaceuticals?
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis... Show more
Profile
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.26B
P/E Ratio
160.00
Total Cash
314.02M
Projected Growth
N/A
Total Debt
42K
Revenue
89.15M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.20
Total Debt/Equity
N/A
Revenue/Share
0.87 USD as % of share price
Fundamentals
SPRY
Capitalization
1.26B
P/E Ratio
160.00
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
314M
Total Cash/Share
3.20
Total Debt
42K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.87%
Revenue
89.1M
ROE
N/A
Book Value
257M
P/B Ratio
4.89
Cash Flow
N/A
Earnings
0.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
14.26
Current Revenue Per Employee
541131.25
Dividends Per Share - Security
N/A
EBITDA
-3.08M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.00
Revenue To Assets
2.74
Shares Held By Institutions
960M
Shares Outstanding - Current
98.1M
Total Liabilities
94.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
21.327
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com